2015
DOI: 10.1007/s11325-015-1254-3
|View full text |Cite|
|
Sign up to set email alerts
|

The Determining Risk of Vascular Events by Apnea Monitoring (DREAM) study: design, rationale, and methods

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(16 citation statements)
references
References 31 publications
0
15
0
1
Order By: Relevance
“…The Determining Risk of Vascular Events by Apnea Monitoring (DREAM) study consists of 2041 veterans from three Veterans Affairs Centers (West Haven, Connecticut; Cleveland, Ohio; and Indianapolis, Indiana) that underwent OSA evaluation between 2000 and 2004, with follow-up through 2012 20 . At enrolment (ie, time of polysomnography), data were collected on demographic and anthropometric characteristics, cardiovascular risk factors, medical comorbidities and other measures, as detailed previously.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…The Determining Risk of Vascular Events by Apnea Monitoring (DREAM) study consists of 2041 veterans from three Veterans Affairs Centers (West Haven, Connecticut; Cleveland, Ohio; and Indianapolis, Indiana) that underwent OSA evaluation between 2000 and 2004, with follow-up through 2012 20 . At enrolment (ie, time of polysomnography), data were collected on demographic and anthropometric characteristics, cardiovascular risk factors, medical comorbidities and other measures, as detailed previously.…”
Section: Methodsmentioning
confidence: 99%
“…At enrolment (ie, time of polysomnography), data were collected on demographic and anthropometric characteristics, cardiovascular risk factors, medical comorbidities and other measures, as detailed previously. 20 Cardiovascular risk was ascertained using the Framingham risk score (FRS; including age, sex, smoking status, presence of diabetes, antihypertensive medication, systolic blood pressure, total cholesterol and high-density lipoprotein levels) 21 and comorbidity burden by the Charlson comorbidity index (CCI). 22 Polysomnographic scoring, variable definitions, classification and continuous positive airway pressure (CPAP) treatment adherence (regular vs not regular) are described in the online supplementary file.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The rationale and methods of this parent study has been previously published. 13 In this study, 1,840 patients underwent comprehensive sleep testing for SDB at 3 VA medical centers (VA Connecticut Healthcare System, West Haven, CT; Richard L. Rhoudebush VAMC, Indianapolis, IN; Louis Stokes VAMC, Cleveland, OH) and were followed for cardiovascular outcomes. The current study is a cross-sectional analysis of the first 982 consecutive veteran patients referred for PSG, a subgroup of DREAM patients who also underwent additional detailed cardiac arrhythmia evaluation.…”
Section: Subjects/study Designmentioning
confidence: 99%
“…Os resultados deste estudo podem prover evidências adicionais para o entendimento da associação entre essas duas condições. 14 Outro objeto de análise diz respeito às alterações na substância branca cerebral, também conhecida como microangiopatia. Estas alterações referem-se a lesões na substância branca subcortical e periventricular, que aparecem com hiperintensidade nas sequências pesadas em T2 e Fluid-atennuated Inversion Recovery (FLAIR) da ressonância nuclear magnética (RNM).…”
Section: Saos Como Fator De Risco Independente Para Doença Cerebrovasunclassified